Cost effectiveness analysis for commonly used human cell and tissue products in the management of diabetic foot ulcers

Health Science Reports, Journal Year: 2024, Volume and Issue: 7(3)

Published: March 1, 2024

This study considers the cost-effectiveness of commonly used cellular, acellular, and matrix‑like products (CAMPs) human origin also known as cell tissue (HCT/Ps) in management diabetic foot ulcers.

Language: Английский